Patent · US Active

Method for temporarily interrupting an extracorporeal blood treatment, control device and blood treatment apparatus

US11918724B2 · kind B2 · utility

0Cited by

6References

14Claims

0Family size

Assignee

Fresenius Medical Care Deutschland GmbH · DE

Inventors

Uwe Hermann · Bernried, DE
Sabine Kipp · Bad Homburg vor der Höhe, DE
Christine Nachbaur-Sturm · Eitorf, DE
Thomas Pusinelli · Schongau, DE
Martin Gruendken · Rosbach, DE
Georg Verch · Wiesbaden, DE

Key dates

Filing date	Jun 20, 2017
Grant date	Mar 5, 2024
Priority date	—
Expiry date	Jun 7, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T137/0324
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

This disclosure relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus. The method comprises activating or controlling a control device provided and configured to bring the blood treatment apparatus into a state in which the blood treatment of the patient can be interrupted with the intention to continue the blood treatment. This disclosure further relates to a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.